IMAB
Price
$2.36
Change
-$0.06 (-2.48%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
197.62M
63 days until earnings call
INDP
Price
$10.97
Change
+$0.44 (+4.18%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
6.03M
48 days until earnings call
Interact to see
Advertisement

IMAB vs INDP

Header iconIMAB vs INDP Comparison
Open Charts IMAB vs INDPBanner chart's image
I-MAB
Price$2.36
Change-$0.06 (-2.48%)
Volume$1.56K
Capitalization197.62M
Indaptus Therapeutics
Price$10.97
Change+$0.44 (+4.18%)
Volume$300
Capitalization6.03M
IMAB vs INDP Comparison Chart in %
Loading...
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMAB vs. INDP commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMAB is a Buy and INDP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 02, 2025
Stock price -- (IMAB: $2.42 vs. INDP: $10.53)
Brand notoriety: IMAB and INDP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMAB: 92% vs. INDP: 6%
Market capitalization -- IMAB: $197.62M vs. INDP: $6.03M
IMAB [@Biotechnology] is valued at $197.62M. INDP’s [@Biotechnology] market capitalization is $6.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMAB’s FA Score shows that 0 FA rating(s) are green whileINDP’s FA Score has 1 green FA rating(s).

  • IMAB’s FA Score: 0 green, 5 red.
  • INDP’s FA Score: 1 green, 4 red.
According to our system of comparison, INDP is a better buy in the long-term than IMAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMAB’s TA Score shows that 5 TA indicator(s) are bullish while INDP’s TA Score has 6 bullish TA indicator(s).

  • IMAB’s TA Score: 5 bullish, 4 bearish.
  • INDP’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, INDP is a better buy in the short-term than IMAB.

Price Growth

IMAB (@Biotechnology) experienced а -1.63% price change this week, while INDP (@Biotechnology) price change was -24.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.51%. For the same industry, the average monthly price growth was +32.88%, and the average quarterly price growth was +3.93%.

Reported Earning Dates

IMAB is expected to report earnings on Sep 02, 2025.

INDP is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (-0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMAB($198M) has a higher market cap than INDP($6.03M). IMAB YTD gains are higher at: 184.706 vs. INDP (-55.341). INDP has higher annual earnings (EBITDA): -16M vs. IMAB (-46.92M). INDP has less debt than IMAB: INDP (59.5K) vs IMAB (3.68M). IMAB (0) and INDP (0) have equivalent revenues.
IMABINDPIMAB / INDP
Capitalization198M6.03M3,284%
EBITDA-46.92M-16M293%
Gain YTD184.706-55.341-334%
P/E RatioN/AN/A-
Revenue00-
Total Cash169MN/A-
Total Debt3.68M59.5K6,192%
FUNDAMENTALS RATINGS
INDP: Fundamental Ratings
INDP
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMABINDP
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 23 days ago
77%
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MORN313.930.92
+0.29%
Morningstar
RXO15.72-0.15
-0.95%
RXO
NPKI8.51-0.29
-3.30%
NPK International Inc
CHSN0.13-0.01
-5.61%
Chanson International Holding
SKYX1.04-0.13
-11.06%
SKYX Platforms Corp

INDP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INDP has been loosely correlated with UNCY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INDP jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
-9.54%
UNCY - INDP
53%
Loosely correlated
-29.85%
ALT - INDP
45%
Loosely correlated
+10.57%
CDTX - INDP
40%
Loosely correlated
-1.50%
IMAB - INDP
39%
Loosely correlated
-5.84%
RVPH - INDP
30%
Poorly correlated
+12.92%
More